Full-Time
Posted on 3/22/2024
High-throughput genomic sequencing services
$78k - $85k/yr
Entry
Fremont, CA, USA
Ultima Genomics improves human health through advanced genomic sequencing technologies, processing large volumes of genetic data to provide insights into biology and diseases. Its unique sequencing architecture allows for extensive data collection, detection of small genetic variations, and routine testing for early disease detection. This focus on breadth, depth, and frequency sets Ultima Genomics apart from competitors, providing clients with high-quality genomic information. The company's goal is to empower researchers and healthcare professionals to achieve breakthroughs in understanding and treating diseases.
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$604.2M
Headquarters
Newark, New Jersey
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Paid Holidays
Paid Vacation
Employee Assistance Program
ROCKVILLE, Md., May 5, 2025 /PRNewswire/ -- Psomagen Inc., a multiomics service laboratory serving academic, pharma, biotech, and clinical customers, will join the Billion Cells Project led by the Chan Zuckerberg Initiative (CZI). The Billion Cells Project aims to develop a landmark single-cell dataset of one billion cells that will be used to train new AI models to advance researchers' understanding of cellular behavior and gene function. Psomagen has begun providing services to participating researchers in April. The project includes collaborations with several other technology partners, including Ultima Genomics, 10x Genomics and Scale Biosciences. Su Hong, CEO of Psomagen, says, "This project represents a transformative step in biomedical research, enabling the identification of novel therapeutic targets and guiding drug development with unparalleled precision. By leveraging AI-powered analysis on vast single-cell datasets, we aim to accelerate the discovery of new ways to restore diseased cells to health
NeoGenomics has partnered with Ultima Genomics to integrate the UG 100 sequencing platform into its Cambridge, UK innovation center, aiming to develop a new range of clinical oncology tests.
Here, AWS is working with the likes of California-based company Ultima Genomics, which has developed software, algorithms and training of its AI models on AWS for its next-generation DNA sequencer.
Ultima Genomics, developer of an ultra-high-throughput sequencing architecture, today announced the launch of its "Count on Us" initiative.
Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now with expanded applications support and integration with leading 'omics' technologies. Over 50% increase in output to 10 to 12 billion reads per wafer and pricing reduced by 20% to $0.24 per million reads, enabling the $80 genome. Increased sensitivity with 5X yield improvement for the SNVQ60 ppmSeq™ mode enabling 30X coverage from as little as 2 nanograms of DNA (1/5th of the cfDNA found in a standard tube of blood)